Daisy Vedder

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Impaired coagulation parameters in early RA are restored by effective antirheumatic therapy: a prospective pilot study.

Impaired coagulation parameters in early RA are restored by effective antirheumatic therapy: a prospective pilot study.

Journal: RMD open

Published: August 05, 2024

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.

Journal: Annals of the rheumatic diseases

Published: March 05, 2023

Cardiovascular risk management in gout patients: do patients benefit from screening in secondary care?

Cardiovascular risk management in gout patients: do patients benefit from screening in secondary care?

Journal: Clinical and experimental rheumatology

Published: August 15, 2022

Correction to: Coagulation in gout: is there a link with disease activity?

Correction to: Coagulation in gout: is there a link with disease activity?

Journal: Clinical rheumatology

Published: March 04, 2022

Routine treatment of rheumatoid arthritis with biologics and targeted agents: changes in patients and their response over 15 years.

Routine treatment of rheumatoid arthritis with biologics and targeted agents: changes in patients and their response over 15 years.

Journal: Annals of the rheumatic diseases

Published: January 21, 2022

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome.

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome.

Journal: Annals of the rheumatic diseases

Published: October 23, 2021

Coagulation in gout: is there a link with disease activity?

Coagulation in gout: is there a link with disease activity?

Journal: Clinical rheumatology

Published: September 27, 2021

Increased cardiovascular risk due to glucocorticoids: how strong is the evidence?

Increased cardiovascular risk due to glucocorticoids: how strong is the evidence?

Journal: Nederlands tijdschrift voor geneeskunde

Published: April 29, 2021

Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial.

Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial.

Journal: BMJ (Clinical research ed.)

Published: December 03, 2020

Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout.

Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout.

Journal: The Lancet. Rheumatology

Published: September 09, 2020

Neutrophil activation identifies patients with active polyarticular gout.

Neutrophil activation identifies patients with active polyarticular gout.

Journal: Arthritis research & therapy

Published: April 23, 2020

A neutrophil signature is strongly associated with increased cardiovascular risk in gout.

A neutrophil signature is strongly associated with increased cardiovascular risk in gout.

Journal: Rheumatology (Oxford, England)

Published: March 23, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026